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The etiopathogenesis of many autoimmune disorders has not been identiﬁed. The aim of
this paper is to focus on the involvement of bacterial exposure, as an environmental fac-
tor, in the pathogenesis of autoimmune pancreatitis (AIP), which is broadly categorized as
autoimmune disorders involving pancreatic lesions. Avirulent and/or commensal bacteria,
which may have an important role(s) as initiating/progressing factors in the pathogenesis
of autoimmune disorder AIP, will be emphasized.
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AUTOIMMUNE DISEASES ASSOCIATED WITH MICROBIAL
INFECTION
Autoimmune diseases arise from an overactive immune response
of the body against tissues normally present in the body. Organ-
speciﬁc autoimmune disease can develop through a combination
of hereditary and environmental factors that regulate adaptive
immune responses to self antigens (Mills, 2011). There are well-
established links between infection and autoimmune diseases.
Several studies have implicated microorganisms in the environ-
mental etiology of autoimmune disorders based on observations
such as, infectionwithChlamydia pneumoniae,humanherpesvirus
6, and Epstein–Barr virus (EBV) are triggered or exacerbated by
multiple sclerosis (Mills, 2011). The regression of autoimmune
thrombocytopenia is seen after the eradication of Helicobac-
ter pylori (Gasbarrini et al., 1998). In Guillain–Barré syndrome
(GBS), amino acid similarities exist between the gangliosides of
the nerve system and the lipopolysaccharides (LPSs) of Campy-
lobacter jejuni, suggesting that sensitization by microbes may be
based on autoimmunity from molecular mimicry between bacte-
ria and the targeted system of the host (Yuki et al., 2004; Houliston
et al., 2011). The link has been attributed to either molecular
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mimicry between pathogen-derived antigens and self antigens or
non-speciﬁc activation of innate immunity leading to a break-
down in immunological tolerance and the development of self
antigen-speciﬁcT cell and antibody response (Mills, 2011).A com-
mon recent theory of the cause of autoimmune diseases is that an
infectious agent triggers a cycle of events,which leads to the upreg-
ulation of the host immune response to self antigens (Aoki, 1999;
Tlaskalová-Hogenova et al., 2004).
AUTOIMMUNE PANCREATITIS AND IgG4-RELATED
DISEASES
Autoimmune pancreatitis (AIP) is a putative autoimmune dis-
ease and is a chronically progressing inﬂammatory disease of the
pancreas (Park et al., 2009; Okazaki et al., 2011a). The morpholog-
ical characteristics of AIP include diffuse or localized enlargement
of the pancreas and irregular narrowing of the main pancreatic
duct. Histologically, the disease is also associated with progres-
sive lymphoplasmacytic inﬁltration, predominantly localized to
the ductal structures, and varying degrees of parenchymal and
acinar destruction (Okazaki et al., 2008).
There are two types of AIP that differ in their clinical features,
such as the gender ratio,mean age, and associated immune-related
diseases. Type 1 AIP is associated with the histological ﬁnding of
lymphoplasmacytic sclerosing pancreatitis (LPSP). Its serological
hallmark is an elevation in the serum levels of the IgG4 subclass
of IgG (Okazaki et al., 2011a). Type 1 AIP appears to be the pan-
creatic manifestation of a systemic disease called IgG4-associated
systemic disease (ISD) or IgG4-related sclerosing disease, affect-
ing not only the pancreas, but also other organs including the bile
duct, retroperitoneum, kidney, lymph nodes, and salivary glands
(Kamisaw and Okamoto, 2006; Okazaki et al., 2011b). Type 2
AIP is a form of idiopathic chronic pancreatitis (ICP), histologi-
cally associated with granulocyte-epithelial lesions (Shimosegawa
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and Kanno, 2009). The pathogenesis of AIP remains unknown.
Genetic associations between susceptibility to the disease and the
human leukocyte antigen (HLA) DRB1∗0405-DQB1∗0401 hap-
lotype (Kawa et al., 2002; Muraki et al., 2006; Ota et al., 2007), Fc
receptor-like gene 3 (FCRL3; Kojima et al., 2007), and the CTLA-4
gene (Umemura et al., 2008) have been suggested.
An outstanding ﬁnding in type 1 AIP is hypergammaglob-
ulinemia and the existence of a high serum concentration for
IgG4, which has been documented in 90% of patients (Hamano
et al., 2001). This occurs in parallel to an abundant IgG4 positive
plasma cell inﬁltration in the pancreatic tissue (Aoki et al., 2005).
The ﬁbroinﬂammatory process characterizing AIP occurs at the
pancreatic basement membranes where IgG4/IgG/complement–
immune complexes are deposited (Detlefsen et al., 2010). IgG1 is
believed to be an opsonizing antibody and activates the comple-
ment classical pathway, namely opsonization of a bacterium by
activated complement and antibodies. Combined opsonization
by both complement and antibodies considerably enhances the
uptake of the bacterium by the phagocyte (Wilson et al., 2011).
AIP is occasionally associated with elevated circulating immune
complex levels, which are signiﬁcantly linked to increased serum
IgG1 and complement activation via the classical pathway (Muraki
et al., 2006). IgG4 is unable to activate the classical pathway of
complements, but binds IgG1, 2, and 3 and forms an immune
complex by Fc–Fc interaction in patients with AIP (Kawa et al.,
2008). Although the role of IgG4 in the immune response and
autoimmunity has not yet been fully elucidated, it may be hypoth-
esized that IgG4 blocks the Fc-mediated effector functions of IgG1
and dampens the inﬂammatory response to an as yet unidentiﬁed
primary trigger of the inﬂammatory process in AIP (Ito et al.,
2010).
IS THERE ANY LINK BETWEEN BACTERIA AND THE
PATHOGENESIS OF AIP?
To which antigens the immunoglobulins in the deposits along
the basal membranes of the pancreatic ducts and acini react
remains unclear and deﬁnitive disease-speciﬁc antibodies have
not been identiﬁed. However, several candidates for AIP-speciﬁc
autoantibodies have been reported, such as anti-lactoferrin (LF;
Okazaki et al., 2000), anti-carbonic anhydrase (CA)-II (Okazaki
et al., 2000), anti-CA IV (Nishimori et al., 2005), anti-pancreatic
secretory trypsin inhibitor (PSTI;Asada et al., 2006), anti-amylase-
alpha (Endo et al., 2009), anti-heat shock protein (HSP) 10 (Tak-
izawa et al., 2009), and anti-plasminogen-binding protein (PBP)
peptide autoantibodies (Frulloni et al., 2009). These putative AIP-
speciﬁc autoantibodies give us some hints toward considering the
possibility that microorganisms are involved in the pathogenesis
of AIP.
In order to survive in a host, a pathogenic microbe has to fol-
low these steps; (i) attach to the host cells for colonization, (ii)
evade the host’s innate and adaptive immune defense and persist
in the host, (iii) obtain iron andother nutrients, (iv) disseminate or
spread within a host, and (v) produce symptoms of disease in the
host (although production of symptoms is not necessary; Wilson
et al., 2011). Following the above mentioned processes, it might
be valid to hypothesize that microbes are the pathogenic factors of
AIP, based upon the possible roles of AIP-speciﬁc antibodies.
(i) LF : Considering the fact that LF is distributed in the ductal
cells of several exocrine organs, including the pancreas, sali-
vary gland, biliary duct, lungs, and renal tubules (Okazaki
et al., 2011b), an anti-LF antibody might be induced as a
consequence of the tissue damage caused bymicrobial infec-
tion and anti-LF might exert direct effects on these ductal
cells of exocrine organs.
Iron is essential for the growth of bacteria. Most path-
ogenic bacteria require iron and thus there is a strong
correlation between iron availability and virulence (Wilson
et al., 2011).However bacteria have to copewith the fact that
iron concentrations in nature are quite low. The concentra-
tion of free iron is particularly low in the host body due to
the actions of host proteins, such as lactoferrin, transferring,
ferritin, and heme, that bind most of the available iron. To
survive in the body, bacteria must have some mechanism
for acquiring this sequestered iron (Wilson et al., 2011).
LF is a glycoprotein, and a member of a transferrin fam-
ily, thus belonging to those proteins capable of binding
and transferring Fe3+ ions (Wilson et al., 2011). LF binds
Fe3+ with an afﬁnity and stability much higher than that of
transferrin in the serum (Valenti and Antonini, 2005). LF
is secreted from the exocrine glands and in speciﬁc gran-
ules of neutrophils, which are the main source of lactoferrin
in blood plasma after degranulation. Neutrophils are at the
front line of the innate immunity process (Wilson et al.,
2011). LF binds iron released from transferrin, which pre-
vents its further usage for bacterial proliferation. Besides
iron, LF is capable of binding a large amount of other com-
pounds and substances such as LPS, heparin, glycosamino-
glycans, or other metal ions and certain DNA and RNA
viruses. The concentration of LF in the blood increases dur-
ing infection and inﬂammation (Adlerova et al., 2008). Since
many bacteria synthesize and secrete small iron-chelating
molecules (siderophores) that can compete with LF for
insoluble Fe3+ ions, the growth-inhibiting activity of the
protein is thus reversed. Iron sequestration by apo-LF,which
is an iron-free form of LF, can effectively inhibit the growth
of many bacterial species (Valenti and Antonini, 2005). LF
has been related to the decreased survival of microorgan-
isms in the host. LF combines with the bacterial surface
through electrostatic and hydrophobic interactions, result-
ing in a perturbation of bacterial membranes. The molec-
ular mechanisms of this bactericidal activity of LF, which
is not related to iron withholding, appears to be similar
for either Gram-negative or Gram-positive bacteria. Tak-
ing these characteristics of LF into consideration, blocking
the LF function by an anti-LF antibody might be beneﬁ-
cial for microbes to get the essential growth element iron
to survive and prolong persistent infection in the body of
AIP patients. Assessing whether or not the anti-LF antibody
obtained from AIP patients actually possesses the block-
ing function of the binding of Fe3+ ion to LF would be of
interest.
(ii) HSP : Mammalian HSP10 and HSP60, also known as chap-
eronins 10 and 60, are mitochondrial proteins involved in
protein folding. HSPs exported to the plasma membrane
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or released from dying cells are believed to be a source of
“danger”signals, informing the innate and adaptive immune
systems of tissue damage induced by various insults includ-
ing infection, toxins, and cellular stress (Johnson et al., 2005;
Shields et al., 2011).
It has not been clariﬁed whether anti-HSP10 pro-
duction is the cause or the consequence of AIP pro-
gression, but HSP10 consistently inhibits LPS-induced
TLR4 signaling by interacting with HSP60 in the extra-
cellular milieu and inhibits LPS-induced secretion of the
pro-inﬂammatory cytokines, TNF-α, IL-6, and the pro-
inﬂammatory chemokine regulated upon activation, nor-
mal T cell expressed and secreted (RANTES) and anti-
inﬂammatory cytokine IL-10 (Johnson et al., 2005). From
this point of view, itmight be possible that the production of
anti-HSP10 antibodies indicates the implication of bacteria
in the pathogenesis of AIP.
(iii) Molecular mimicry : Homology between alpha-CA of H.
pylori and human CA-II has been also reported. Guarneri
et al. showed a signiﬁcant homology between human CA-II
and α-CA of H. pylori. Moreover, the homologous segments
contained the bindingmotif of DRB1∗0405 (Guarneri et al.,
2005). Notably, the possession of the HLA-DRB1∗0405-
DQB1∗0401 genotype confers a risk for AIP development
(Ota et al., 2007). The anti-PBP peptide antibody was newly
identiﬁed inpatientswithAIP. Frulloni et al. (2009) reported
that 94% of AIP patients, but only 5% of pancreatic cancer
patients, exhibit IgG antibodies to a PBP that is homologous
to the human protein ubiquitin-protein ligase E3 compo-
nent n-recognin 2 (UBR2), which is expressed in pancreatic
acinar cells and is also homologous to the PBP of H. pylori.
These data suggest that H. pylori infection may trigger AIP
in genetically predisposed subjects through autoimmune
responses triggered by molecular mimicry.
(iv) CAs: Immunization with CA-II or LF has been reported
to induce systemic lesions such as pancreatitis, sialadenitis,
cholangitis, and interstitial nephritis (Nishimori et al., 1995;
Ueno et al., 1998). The distribution of CA-II and IV are both
in the ductal cells of several exocrine organs, including the
pancreas, salivary gland,biliary duct, lungs and renal tubules
(Okazaki et al., 2011b). Nishimori et al. (2005) reported
that serum antibodies to CAs I and II might be detected
in patients with Sjögren’s syndrome and ICP perhaps as a
consequence of the cross-reactivity of an antibody against
another unknown antigen that mimics CAs I and II. Expres-
sion of CA IV is more restricted in tissues and cell types in
the inﬂamed lesions that have been observed in patients
with AIP and related diseases. It has been suggested that CA
IV is more likely to function as the target antigen (Nishi-
mori et al., 2005). CAs on the luminal surface of the ductal
cells would eliminate excess acid from the ductal lumen,
inhibiting spontaneous autoactivation of trypsin and other
proteases (Nishimori et al., 1999), and therefore may con-
tribute to attrition of bacterial killing by these enzymes in
the pancreas.
(v) PSTI : PSTI, a 56-amino-acid peptide, is synthesized in
pancreatic acinar cells, distributed in the ductal cells of
several exocrine organs, including the pancreas, salivary
gland, biliary duct, lungs, and renal tubules, and colocal-
izes with trypsinogen in zymogen granules. In addition to
its protective role in acinar cells, PSTI inhibits activation of
trypsinogen in the pancreatic duct (Asada et al., 2006). It
might be beneﬁcial for preventing degradation of bacterial
pathogen(s). Additionally, it would be of interest to study
whether or not the anti-PSTI antibody inhibits the function
of PSTI.
Besides putative AIP-speciﬁc autoantibodies, other fac-
tors such as channel(s), transporters, and some of AIP
associated genes also give us hints to consider the possible
involvement of bacteria in the pathogenesis of AIP.
(vi) AQP1: Aquaporin (AQP) water channels are intrinsic mem-
brane proteins expressed most of the cell types which
have high osmotic water permeability. Among them AQP1
(Aquaporin 1) is a predominant water channel expressed in
the plasmamembranes of humanpancreatic ducts (Ko et al.,
2009). Altered tissue water homeostasis may contribute to
edema formation during various stress including bacterial
infection (Schweitzer et al., 2007). AQP1 indeed contributes
to maintain water homeostasis even in cells with plasma
membrane damage following insult with bacterial infec-
tion (Schweitzer et al., 2007). Interestingly,AQP1 expression
was signiﬁcantly increased in plasma membranes of pancre-
atic ducts in AIP (Ko et al., 2009). Upregulation of AQP1
expression seen in pancreatic ducts of patients with AIP is
speculated to be caused by the reduced ﬂuid secretion from
the pancreas as compensation (Ko et al., 2009).
Membranes serve as a barrier to prevent pathogenic bac-
teria from entering the nutrient-rich host cytosol (Radtke
and O’Riordan, 2008). Aquaporins may be an integral
part of infection and pathology caused by some microbial
pathogens, so regulation of aquaporin expression and func-
tion is a key aspect of host–pathogen interaction (Radtke
and O’Riordan, 2008). In addition, AQP1 regulates swelling
of secretory vesicles, associated with pathogen-containing
vacuoles (PCV). AQP1-dependent modulation of PCV was
triggered by bacterial induced membrane damage and ion
ﬂux (Radtke and O’Riordan, 2008). As described above,
in the pancreas of AIP patients, expression of AQP1 was
increased markedly, not only to on the plasma membrane
but also in the cytoplasm of pancreatic duct cells. To clarify
the association between the upregulation of AQP1 in the
cytoplasm and PCV would be of interest.
(vii) CFTR: It was reported that aberrant cystic ﬁbrosis trans-
membrane conductance regulator (CTFR) localization in
the pancreatic ducts was observed in AIP patients. The
CTFR regulates overall pancreatic ductal ﬂuid/overall ion
transport across most epithelia and plays a central role in
pancreatic ductal HCO−3 secretion (Ko et al., 2010). Altered
acidity of the pancreatic ﬂuid may affect growth of the
normal bacterial inhabitant and immunity of the upper
intestinal environment.
(viii) ABCF1: The ABCF1 (ATP-binding cassette, sub-family F)
gene proximal to C3-2-11 microsatellite in HLA class
I regions, is thought to be one of the HLA-linked
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susceptibility regions forAIP (Ota et al., 2007). At this point,
biological function of the putative ABCF1 protein is mostly
speculative, however it is thought to be regulated by TNF-
α, a prime cytokine in inﬂammatory reactions (Ota et al.,
2007). From this point, it could be possible to suspect that
bacteria would lie in the pathogenesis of AIP.
ANIMAL MODELS OF AIP
Several experimentalmodels of AIP have been described (Table 1).
As for speciﬁc induction models, CA-II, LF, and amylase-speciﬁc
T cells could be listed (Nishimori et al., 1995; Uchida et al., 2002;
Davidson et al., 2005). As for the microorganisms related induc-
tion group, virus-induced AIP models, such as C57BL/6 mice
infected with the murine leukemia retrovirus LP-BM5, developed
histological ﬁndings similar to human AIP (Suzuki et al., 1993;
Watanabe et al., 2003). The spontaneous development of pan-
creatitis via an autoimmune mechanism in MRL/Mp mice is
accelerated by the administration of polyinosinic:polycytidylic
acid (poly I:C), a synthetic double-stranded RNA and TLR 3
ligand (Qu et al., 2002; Soga et al., 2009; Asada et al., 2010;
Nishio et al., 2011). Sensitization occurs with not only viral
components, such as double-stranded RNA poly I:C, but also
bacterial LPS in interleukin (IL)-10-deﬁcient mice (Nishio et al.,
2011). TLRs play important roles in innate immunity by initiat-
ing intracellular signaling to macrophages and dendritic cells after
stimulation with various antigens. The majority of known TLRs
mediate the development of Th1 cell-inducing dendritic cells (Li
et al., 2009). Thus, pattern-recognition receptors (PRRs) that bind
Table 1 | Experimental animal models of autoimmune pancreatitis.
Animal Organs with lesions Induction Effector cells Reference
MICROORGANISMS RELATED INDUCTION
SMA mice Pancreas K. pneumoniae,
pancreatic extract
? Yamaki et al. (1980)
MRL/Mp, MRL/lpr mice Pancreas poly (I:C) CD4+ T cells Qu et al. (2002)
MRL/Mp mice Pancreas poly (I:C) ? Soga et al. (2009)
Asada et al. (2010)
Nishio et al. (2011)
IL-10KO mice Pancreas poly (I:C), LPS ? Nishio et al. (2011)
C57BL/6 mice Pancreas, salivary
gland, bile duct,
kidney, lung
LP-BM5 CD4+ T cells Suzuki et al. (1993)
Watanabe et al. (2003)
C57BL/6 mice Pancreas, salivary
gland
E. coli T cells Haruta et al. (2010a)
SPECIFIC INDUCTION (EXCEPT MICROORGANISMS)
DA(RP) rats ? Amylase-speciﬁc
T cell
CD4+ and CD8+ T cells Davidson et al. (2005)
Lewis rats Pancreas
PL/J mice (H-2u), (H-2s) Pancreas, salivary
gland
CA-II ? Nishimori et al. (1995)
nTx-BALBc mice and nude mice Pancreas, salivary
gland, bile duct
CA-II, LF CD4+ Th1 cells Uchida et al. (2002)
SPONTANEOUS INDUCTION
MRL/Mp mice Pancreas, salivary
gland
Spontaneous T cells Kanno et al. (1992)
Hosaka et al. (1996)
aly/aly mice Pancreas Spontaneous CD4+ T cells Tsubata et al. (1996)
Nakamura et al. (2007)
Wang et al. (2010)
WBN/Kob rats Pancreas, salivary
gland, thyroid, bile
duct, kidney
Spontaneous CD8+ T cells Sakaguchi et al. (2008)
MHC-II −/− mice Pancreas Spontaneous CD8+ T cells Vallance et al. (1998)
T-cell+ HLA-DR*0405Ab0 NOD mice Pancreas Spontaneous ? Freitag et al. (2010)
Tgfbr2(fspKO) mice Pancreas Spontaneous CD4+ T cells Boomershine et al. (2009)
NOD.CD28KO mice Pancreas Spontaneous CD4+ T cells Meagher et al. (2008)
CA-II, carbonic anhydrase II, LF, lactoferrin; PSTI, pancreatic secretary trypsin inhibitor; poly I:C, polyinosinic:polycytidylic acid; nTx, neonatal thymectomy. Modiﬁed
from references Frulloni et al. (2009), Takizawa et al. (2009), andYanagisawa et al. (2011).
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pathogen-associated molecular patterns (PAMPs) may trigger an
autoimmune response.
As for speciﬁc induction, thymectomizedmice immunizedwith
CA-II or LF develop a pathology that closely resembles AIP under
a regulatory T (Treg) cell-depleted background (Uchida et al.,
2002). However, T cells speciﬁc for CA-II and LF were unable to
induce pancreatitis in the adoptive transfer of an amylase-speciﬁc
rat model (Davidson et al., 2005), suggesting that autoantibodies
against these enzymes inAIP represent a late consequence of tissue
destruction.
As for the spontaneous induction group, recently, the spon-
taneous development of AIP in CD4+ T cell-competent HLA-
DR∗0405 transgenic Ab0 NOD mice (Freitag et al., 2010), Treg-
deﬁcient backgrounds in neonatally thymectomized mice (Uchida
et al., 2002), NOD.CD28 knockout mice (Meagher et al., 2008),
WBN/Kob rats (Sakaguchi et al., 2008), and Tgfbr2fsp knock-
out mice (Boomershine et al., 2009) have demonstrated genetic
polymorphisms of the effector cells in the etiologies of AIP. How-
ever, because these mice are genetically engineered they may not
completely reﬂect the onset of human diseases.
COMMENSAL BACTERIA-INDUCED MOUSE MODEL OF AIP
Instances of where microbial antigens might underlie the patho-
genesis of IgG4-related disease have been reported (Akitake et al.,
2010; Watanabe et al., 2012). We previously reported that when
C57BL/6 mice were inoculated intraperitoneally (i.p.) with heat-
killed E. coli weekly for 8weeks, marked cellular inﬁltration
with ﬁbrosis was observed in the exocrine pancreas accompanied
by a high serum gamma globulin level and the production of
autoantibodies against CA-II and LF. Bacterial infection appar-
ently triggered AIP-like pathological alterations in mice that
strikingly resembled AIP in humans (Haruta et al., 2010a).
C57BL/6 mice inoculated weekly with E. coli for 8 weeks were
utilized as donors, and the spleens were intravenously transferred
to RAG2−/− mice. The pancreas in the recipient RAG2−/− mice
showed cellular inﬁltration in the exocrine pancreas, especially
around the pancreatic ducts, indicating that the E. coli-inoculated
mouse spleen cells possess the ability to reproduce pathological
alterations in the pancreas of naïvemice. Similarly,when the spleen
cells of donor S. intermedius-inoculated mice were transferred to
RAG2−/− mice, primary biliary cirrhosis (PBC)-like cholangitis
FIGURE 1 | Hypothetical pathogenesis of AIP. Under normal condition,
commensal bacteria are not pathogenic and may exist in the host from
early life. However, additional factor(s) such as genetic factors would be
synchronized with the existence of microorganisms, and the progression
switch to generate the status of AIP would be turned on. During the
initiation phase, PAMPs and/or non-pathogenic MAMPs trigger and
upregulate the innate immune system. These respective PAMPs/MAMPs
and DAMPs induce inﬂammatory response PRRs. Second, the progressive
phase features the persistence of this PAMPs/MAMPs attack or
stimulation by a molecular-mimicking antigen, perhaps released as DAMPs
and/or exposure to or stimulation from commensal ﬂora possessing the
same antigenic epitope that the initial pathogen possessed, thereby
upregulating the host immune response to the target antigen. These
slowly progressive steps eventually lead to the development of
autoimmune diseases. Modiﬁed from previous reports (Haruta et al.,
2010a; Yanagisawa et al., 2011).
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in the liver was induced, similar to that seen in the donor (Haruta
et al., 2010b). The AIP-like inﬂammatory region in the pan-
creases of recipient mice with spleen cells transferred from E. coli-
inoculatedmice (Haruta et al., 2010a), showed thatmost of the cel-
lular inﬁltrates in the target organs were CD3-positive, indicating
that these cells in both models originated from the donor mice.
The criteria for determining whether a condition may be con-
sidered to be autoimmune, according toWitebsky’s postulateswith
modern revision by Rose and Bona (1993), include (i) indirect
evidence based on the reproduction of the autoimmune disease in
experimental animals, (ii) direct evidence of the transfer of path-
ogenic antibodies, or (iii) pathogenic T cells and indirect evidence
of the isolation of autoantibodies or autoreactive T cells. Several
lines of evidence have suggested that repeated E. coli-inoculated
AIP-like inﬂammation in the C57BL/6 mice pancreas is possibly
of autoimmune origin.
It is worth mentioning that long before the concept of AIP
was proposed as a deﬁnite disease entity, Yamaki et al. (1980) had
established inﬂammation of the exocrine pancreas using syngeneic
pancreatic antigens. Repeated injection of pancreatic extract from
syngeneic mice mixed with capsular polysaccharide (CPS) of the
Klebsiella pneumoniae type 1 Kasuya strain (CPS-K), as an adju-
vant, caused pathological alteration in the pancreas, consistent
with inﬁltration by lymphocytes, plasma cells and mononuclear
cells, degradation and lysis of the acinar cells, and destruction of
the lobular architecture, replacement of fatty tissue and ﬁbrous
connective tissue and anti-pancreas antibody production. No his-
tological changes were observed in tissues other than the pancreas
and either CPS-K or the pancreatic extract alone were insufﬁcient
to induce inﬂammation in the pancreas. K. pneumoniae is one of
the commonly found bacteria in Enterobacteriaceae (Yamaki et al.,
1980), the natural habitat of the intestinal tract, and it is an oppor-
tunistic bacterium. The CPS is a voluminous outer layer and is
involved in protection against complement deposition that occurs
mainly in the inhibition of macrophage phagocytosis (Evrard et al.,
2010). It is of great interest that inﬂammation had been induced
only when the syngeneic pancreatic antigen and bacterial compo-
nent both existed, which suggest the possibility that the bacterial
component may exhibit an adjuvant effect to the antigen.
CONCLUSION
It is currently believed that themicrobiota is essential for the devel-
opment of a functional immune system and the gutmicrobiota has
a far-reaching inﬂuence on the immune system, beyond the gas-
trointestinal tract, i.e., within and outside the gut. In other words,
gut microbiota has a greater inﬂuence on the systemic immune
system than previously anticipated (Kranich et al., 2011). From
the aspect of gut microbiota and autoimmunity, several animal
models have been reported. For instance, it was reported that the
relationship between certain harmful species of gut bacteria affect
T cell populations in the periphery and thereby control the devel-
opment of autoimmune arthritis. Segmented ﬁlamentous bacte-
ria could promote experimental autoimmune encephalomyelitis
(Kranich et al., 2011).
We propose a hypothetical pathogenesis of bacteria-induced
AIP. Under normal conditions, commensal bacteria are not patho-
genic and may exist in the host from early life. However, additional
factor(s) such as genetic factors including the haplotype of class
II antigen of the major histocompatibility complex (MHC) and
so on would be synchronized with the existence of microor-
ganisms, and the progression switch to generate the status of
AIP would be turned on. During the initiation phase, infection
with microorganisms possessing PAMPs and/or non-pathogenic
microorganisms associated molecular patterns (MAMPs) trigger
and upregulate the innate immune system. In this step, we are
especially focusing on the commensal bacteria. Inﬂammatory T
cells are induced by molecules derived from pathogens or com-
mensal microorganisms, as well as by endogenous stress-induced
self molecules. These respective MAMPs and damage-associated
molecular patterns (DAMPs) induce inﬂammatory T cells either
indirectly, through the induction of pro-inﬂammatory cytokine
production by binding to pattern recognition receptors (PRRs) on
innate immune cells, or directly, by binding to pathogen-derived
peptide speciﬁc receptors on T cells (Mills, 2011).
Second, the progressive phase features the persistence of this
PAMPs/MAMPsattack, stimulationbymolecular-mimicking anti-
gen, perhaps released as DAMPs, exposure to or stimulation from
commensal ﬂora possessing the same antigenic epitope, and/or
non-speciﬁc activation of innate immunity. These slowly progres-
sive steps lead to a breakdown in immunological tolerance and the
development of self antigen-speciﬁc T cell and antibody responses
(Mills, 2011) and eventually establish the autoimmune diseases.
Throughout these processes, TLRs might participate as the key
member of PRRs involved in driving autoimmune inﬂammation
(Mills, 2011; Figure 1). Taking these considerations together, the
pancreas is the ﬁeld of the speciﬁc inﬂammation which would be
triggered by the interaction with microorganisms, and a provider
of the autoantigen to induce the production of autoantibodies.
These sequential processes would be orchestrated to constitute the
status of AIP.
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